Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Although hepatitis C virus (HCV) infection is very common, identification of patients during acute infection is rare. Consequently, little is known about the immune response during this critical stage of the disease. We analyzed the T lymphocyte response during and after acute resolving HCV infection in three persons, using interferon (IFN)-γ enzyme-linked immunospot (ELISPOT) and human histocompatibility leukocyte antigen (HLA) peptide tetramer assays. Acute infection was associated with a broadly directed T helper and cytotoxic T lymphocyte (CTL) response, which persisted after resolution of clinical hepatitis and clearance of viremia. At the earliest time point studied, highly activated CTL populations were observed that temporarily failed to secrete IFN-γ, a “stunned” phenotype, from which they recovered as viremia declined. In long-term HCV-seropositive persons, CTL responses were more common in persons who had cleared viremia compared with those with persistent viremia, although the frequencies of HCV-specific CTLs were lower than those found in persons during and after resolution of acute HCV infection. These studies demonstrate a strong and persistent CTL response in resolving acute HCV infection, and provide rationale to explore immune augmentation as a therapeutic intervention in chronic HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978 · cited 6×
“Finally, the cells might have undergone a process of antigen-induced partial deactivation or exhaustion (22, 26, 38, 50).”
BackgroundResultInfluentialCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
Self-citationMoskophidis, D., Lechner, F., Pircher, H., & Zinkernagel, R. M. (1993) · Nature · doi:10.1038/362758a0 · Cited by 1,240
Self-citationViral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183
Serial triggering of many T-cell receptors by a few peptide–MHC complexes
Valitutti, S., Müller, S., Cella, M., Padovan, E., & Lanzavecchia, A. (1995) · Nature · doi:10.1038/375148a0 · Cited by 1,128
Cited by
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
“In contrast, during chronic HCV infection, CD8 + T cells that cannot make IFN-γ have been reporte”
BackgroundLauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Self-citationCD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 1,975
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., et al. (2019) · Nature · doi:10.1038/s41586-019-1325-x · Cited by 1,646
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571
Self-citationDeterminants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., & Chisari, F. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1395 · Cited by 1,189
Overcoming T cell exhaustion in infection and cancer
Pauken, K. E., & Wherry, E. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.008 · Cited by 1,171
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
Amara, R. R., Villinger, F., Altman, J. D., Lydy, S. L., O'Neil, S. P., Staprans, S. I., Montefiori, D. C., Xu, Y., Herndon, J. G., Wyatt, L. S., et al. (2001) · Science · doi:10.1126/science.292.5514.69 · Cited by 133
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,084
Immune control of HIV-1 after early treatment of acute infection
Rosenberg, E. S., Altfeld, M., Poon, S. H., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K., D'Aquila, R. T., Goulder, P. J. R., & Walker, B. D. (2000) · Nature · doi:10.1038/35035103 · Cited by 1,002
Self-citationMechanism of action of interferon and ribavirin in treatment of hepatitis C
Feld, J. J., & Hoofnagle, J. H. (2005) · Nature · doi:10.1038/nature04082 · Cited by 992
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Memory CD8 T-Cell Differentiation during Viral Infection
Wherry, E. J., & Ahmed, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5535-5545.2004 · Cited by 868
Genetic diversity and evolution of hepatitis C virus – 15 years on
Simmonds, P. (2004) · Journal of General Virology · doi:10.1099/vir.0.80401-0 · Cited by 865
The Natural History of Hepatitis C Virus (HCV) Infection
Chen, S. L., & Morgan, T. R. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.47 · Cited by 860
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J.-H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., & Walker, C. M. (2003) · Science · doi:10.1126/science.1088774 · Cited by 830
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Adaptive immune responses in acute and chronic hepatitis C virus infection
Bowen, D. G., & Walker, C. M. (2005) · Nature · doi:10.1038/nature04079 · Cited by 756
Hepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
Shoukry, N. H., Grakoui, A., Houghton, M., Chien, D. Y., Ghrayeb, J., Reimann, K. A., & Walker, C. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030239 · Cited by 656
T‐cell exhaustion: characteristics, causes and conversion
Yi, J. S., Cox, M. A., & Zajac, A. J. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03255.x · Cited by 645
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H., & Chisari, F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608299 · Cited by 639
Wedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., & Rehermann, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3447 · Cited by 634
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
Miller, J. D., van der Most, R. G., Akondy, R. S., Glidewell, J. T., Albott, S., Masopust, D., Murali-Krishna, K., Mahar, P. L., Edupuganti, S., Lalor, S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.020 · Cited by 601
Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G., & Ferrari, C. (2006) · Journal of Virology · doi:10.1128/jvi.01177-06 · Cited by 588
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Sprent, J., & Surh, C. D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100101.151926 · Cited by 534
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
Rehermann, B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39133 · Cited by 531
CD8 + T‐cell memory in tumor immunology and immunotherapy
Klebanoff, C. A., Gattinoni, L., & Restifo, N. P. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00391.x · Cited by 511
Sustained Dysfunction of Antiviral CD8+T Lymphocytes after Infection with Hepatitis C Virus
Gruener, N. H., Lechner, F., Jung, M.-C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B., Sullivan, J., Phillips, R., Pape, G. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5550-5558.2001 · Cited by 495
Self-citationRadziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02021-06 · Cited by 483
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
Wieland, S. F., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9369-9380.2005 · Cited by 457
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
Tseng, C.-T. K., & Klimpel, G. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011145 · Cited by 447
DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442
von Hahn, T., Yoon, J. C., Alter, H., Rice, C. M., Rehermann, B., Balfe, P., & McKeating, J. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.008 · Cited by 425
Gamadia, L. E., Remmerswaal, E. B. M., Weel, J. F., Bemelman, F., van Lier, R. A. W., & Ten Berge, I. J. M. (2003) · Blood · doi:10.1182/blood-2002-08-2502 · Cited by 422
T cells and viral persistence: lessons from diverse infections
Klenerman, P., & Hill, A. (2005) · Nature Immunology · doi:10.1038/ni1241 · Cited by 412
Self-citationErickson, A. L., Kimura, Y., Igarashi, S., Eichelberger, J., Houghton, M., Sidney, J., McKinney, D., Sette, A., Hughes, A. L., & Walker, C. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00245-x · Cited by 408
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., Townsend, R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003155 · Cited by 405
Self-citationBoettler, T., Spangenberg, H. C., Neumann-Haefelin, C., Panther, E., Urbani, S., Ferrari, C., Blum, H. E., von Weizsäcker, F., & Thimme, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7860-7867.2005 · Cited by 404
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
Gupta, P. K., Godec, J., Wolski, D., Adland, E., Yates, K., Pauken, K. E., Cosgrove, C., Ledderose, C., Junger, W. G., Robson, S. C., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005177 · Cited by 396
Self-citationAltfeld, M., Rosenberg, E. S., Shankarappa, R., Mukherjee, J. S., Hecht, F. M., Eldridge, R. L., Addo, M. M., Poon, S. H., Phillips, M. N., Robbins, G. K., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.169 · Cited by 385
Self-citationHarari, A., Petitpierre, S., Vallelian, F., & Pantaleo, G. (2004) · Blood · doi:10.1182/blood-2003-04-1203 · Cited by 378
Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F. A., Alter, H. J., & Chang, K.-M. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.026 · Cited by 369
Immune responses and immunopathology in acute and chronic viral hepatitis
Shin, E.-C., Sung, P. S., & Park, S.-H. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.69 · Cited by 365
CD8 T cell dysfunction during chronic viral infection
Shin, H., & Wherry, E. J. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.06.004 · Cited by 348
Swadling, L., Capone, S., Antrobus, R. D., Brown, A., Richardson, R., Newell, E. W., Halliday, J., Kelly, C., Bowen, D., Fergusson, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009185 · Cited by 343
Self-citationBoni, C., Penna, A., Ogg, G. S., Bertoletti, A., Pilli, M., Cavallo, C., Cavalli, A., Urbani, S., Boehme, R., Panebianco, R., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.23045 · Cited by 339
Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
Chang, K.-M., Thimme, R., Melpolder, J. J., Oldach, D., Pemberton, J., Moorhead-Loudis, J., McHutchison, J. G., Alter, H. J., & Chisari, F. V. (2001) · Hepatology · doi:10.1053/jhep.2001.21162 · Cited by 336
T cell exhaustion during persistent viral infections
Kahan, S. M., Wherry, E. J., & Zajac, A. J. (2015) · Virology · doi:10.1016/j.virol.2014.12.033 · Cited by 324
Folgori, A., Capone, S., Ruggeri, L., Meola, A., Sporeno, E., Ercole, B. B., Pezzanera, M., Tafi, R., Arcuri, M., Fattori, E., et al. (2006) · Nature Medicine · doi:10.1038/nm1353 · Cited by 322
CD8 Epitope Escape and Reversion in Acute HCV Infection
Timm, J., Lauer, G. M., Kavanagh, D. G., Sheridan, I., Kim, A. Y., Lucas, M., Pillay, T., Ouchi, K., Reyor, L. L., zur Wiesch, J. S., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041006 · Cited by 318
Self-citationHislop, A. D., Annels, N. E., Gudgeon, N. H., Leese, A. M., & Rickinson, A. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011692 · Cited by 317
Immunity in response to particulate antigen-delivery systems
STORNI, T., KUNDIG, T., SENTI, G., & JOHANSEN, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 317
Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs
Frese, M., Schwärzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O., & Bartenschlager, R. (2002) · Hepatology · doi:10.1053/jhep.2002.31770 · Cited by 314
Flying Under the Radar: The Immunobiology of Hepatitis C
Dustin, L. B., & Rice, C. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141602 · Cited by 313
Prospects for a vaccine against the hepatitis C virus
Houghton, M., & Abrignani, S. (2005) · Nature · doi:10.1038/nature04081 · Cited by 312
Lechner, F., Gruener, N. H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A. R., Cerny, A., Phillips, R., Ferrari, C., Pape, G. R., et al. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200009)30:9<2479::aid-immu2479>3.0.co;2-b · Cited by 312
Self-citationReversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
Tsai, S., Shameli, A., Yamanouchi, J., Clemente-Casares, X., Wang, J., Serra, P., Yang, Y., Medarova, Z., Moore, A., & Santamaria, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.015 · Cited by 309
Cellular immune selection with hepatitis C virus persistence in humans
Cox, A. L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X.-H., Yang, H.-C., Sidney, J., Sette, A., Pardoll, D., Thomas, D. L., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050121 · Cited by 306
Innate and adaptive immune responses in HCV infections
Heim, M. H., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.035 · Cited by 305
Auffermann-Gretzinger, S., Keeffe, E. B., & Levy, S. (2001) · Blood · doi:10.1182/blood.v97.10.3171 · Cited by 304
Accapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L. V., Cividini, A., Abrignani, S., Mondelli, M. U., & Barnaba, V. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420515 · Cited by 303
Lauer, G. M., Barnes, E., Lucas, M., Timm, J., Ouchi, K., Kim, A. Y., Day, C. L., Robbins, G. K., Casson, D. R., Reiser, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.015 · Cited by 303
Self-citationHepatitis C genotype 4: What we know and what we don't yet know†
Kamal, S. M., & Nasser, I. A. (2008) · Hepatology · doi:10.1002/hep.22127 · Cited by 301
Nakamoto, N., Kaplan, D. E., Coleclough, J., Li, Y., Valiga, M. E., Kaminski, M., Shaked, A., Olthoff, K., Gostick, E., Price, D. A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.033 · Cited by 299
Keilholz, U., Weber, J., Finke, J. H., Gabrilovich, D. I., Kast, W. M., Disis, M. L., Kirkwood, J. M., Scheibenbogen, C., Schlom, J., Maino, V. C., et al. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200203000-00001 · Cited by 298
Human CD8+ T-cell differentiation in response to viruses
van Lier, R. A. W., ten Berge, I. J. M., & Gamadia, L. E. (2003) · Nature Reviews Immunology · doi:10.1038/nri1254 · Cited by 297
Maheshwari, A., Ray, S., & Thuluvath, P. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61116-2 · Cited by 295
Dolganiuc, A., Oak, S., Kodys, K., Golenbock, D. T., Finberg, R. W., Kurt-Jones, E., & Szabo, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.067 · Cited by 294
CD81 is an entry coreceptor for hepatitis C virus
Cormier, E. G., Tsamis, F., Kajumo, F., Durso, R. J., Gardner, J. P., & Dragic, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402253101 · Cited by 290
Penna, A., Pilli, M., Zerbini, A., Orlandini, A., Mezzadri, S., Sacchelli, L., Missale, G., & Ferrari, C. (2007) · Hepatology · doi:10.1002/hep.21541 · Cited by 285
Ablation of CD8 and CD4 T Cell Responses by High Viral Loads
Fuller, M. J., & Zajac, A. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.477 · Cited by 276
Rushbrook, S. M., Ward, S. M., Unitt, E., Vowler, S. L., Lucas, M., Klenerman, P., & Alexander, G. J. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7852-7859.2005 · Cited by 275
Self-citationStrickland, T. G. (2006) · Hepatology · doi:10.1002/hep.21173 · Cited by 272
Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G., Hoofnagle, J. H., Liang, T. J., Heller, T., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.08.066 · Cited by 270
Immune Responses to HCV and Other Hepatitis Viruses
Park, S.-H., & Rehermann, B. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.010 · Cited by 265
Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions
Nascimbeni, M., Shin, E.-C., Chiriboga, L., Kleiner, D. E., & Rehermann, B. (2004) · Blood · doi:10.1182/blood-2003-12-4395 · Cited by 263
Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees
Bigger, C. B., Guerra, B., Brasky, K. M., Hubbard, G., Beard, M. R., Luxon, B. A., Lemon, S. M., & Lanford, R. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13779-13792.2004 · Cited by 259
Day, C. L., Lauer, G. M., Robbins, G. K., McGovern, B., Wurcel, A. G., Gandhi, R. T., Chung, R. T., & Walker, B. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12584-12595.2002 · Cited by 258
Self-citationMolecular mechanisms of viral hepatitis induced hepatocellular carcinoma
D'souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5759 · Cited by 257
Goulder, P. J. R., Altfeld, M. A., Rosenberg, E. S., Nguyen, T., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Muckerjee, J. S., Phillips, M. N., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.181 · Cited by 255
Self-citationKinetics of the Immune Response During Hbv and Hcv Infection
Bertoletti, A., & Ferrari, C. (2003) · Hepatology · doi:10.1053/jhep.2003.50310 · Cited by 254
van de Laar, T. J., Matthews, G. V., Prins, M., & Danta, M. (2010) · AIDS · doi:10.1097/qad.0b013e32833c11a5 · Cited by 252
Tracking T cells with tetramers: new tales from new tools
Klenerman, P., Cerundolo, V., & Dunbar, P. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri777 · Cited by 190
Self-citationOscillating CD8+ T Cell Effector Functions after Antigen Recognition in the Liver
Isogawa, M., Furuichi, Y., & Chisari, F. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.005 · Cited by 186
Amelioration of hepatic fibrosis by NK cell activation
Muhanna, N., Tair, L. A., Doron, S., Amer, J., Azzeh, M., Mahamid, M., Friedman, S., & Safadi, R. (2011) · Gut · doi:10.1136/gut.2010.211136 · Cited by 127
Rigopoulou, E. I., Abbott, W. G. H., Haigh, P., & Naoumov, N. V. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.06.003 · Cited by 98
Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
Johansson, D. X., Ljungberg, K., Kakoulidou, M., & Liljeström, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029732 · Cited by 98
“This raises additional concerns since persisting viral infections in humans, such as HIV or hepatitis C virus, are associated with dysfunctional CTL responses [45,46].”
BackgroundStatistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials
Moodie, Z., Huang, Y., Gu, L., Hural, J., & Self, S. G. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.07.015 · Cited by 68
HCV-Specific T Cell Responses During and After Chronic HCV Infection
Luxenburger, H., Neumann-Haefelin, C., Thimme, R., & Boettler, T. (2018) · Viruses · doi:10.3390/v10110645 · Cited by 64
Chua, B. Y., Eriksson, E. M., Brown, L. E., Zeng, W., Gowans, E. J., Torresi, J., & Jackson, D. C. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.032 · Cited by 54
Bihl, F. K., Loggi, E., Chisholm, J. V., Hewitt, H. S., Henry, L. M., Linde, C., Suscovich, T. J., Wong, J. T., Frahm, N., Andreone, P., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-20 · Cited by 39
Single MHC‐I Expression Promotes Virus‐Induced Liver Immunopathology
Xu, H. C., Huang, J., Pandyra, A. A., Pandey, P., Wang, R., Zhang, Z., Zhuang, Y., Gertzen, C. G. W., Münk, C., Herebian, D., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1913 · Cited by 9
Metadata
- Authors
- Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-05-01
- Volume
- 191
- Issue
- 9
- Pages
- 1499-1512
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2111359040
- Cited by
- 1,269
- References
- 48
- FWCI
- 54.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.